Company / Interest Expense per Share
enGene Holdings Inc. Interest Expense per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$7.15
FY2023
5-year range
$2.17 / $7.15
FY2022-FY2023
Trend
+229.2%
vs FY2022
Sector context
#3 of 46
Health Care
What the data says
Among 46 Health Care companies, enGene Holdings Inc. is in the bottom 7% for interest expense per share.
Based on SEC 10-K filings.
7.15 in FY2023. Ranks 3rd among 46 companies in Health Care.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 46This company $7.15 Sector average $17.44
▼
-59.0% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 229.2% year-over-year.
- Ranks #3 out of 46 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $7.15 | +229.2% |
| FY2022 | $2.17 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026